Registry of Patients for MRI With Non-MRI Conditional Pacemakers and ICD Non-MRI Conditional Pacemakers and ICD

Magnetic Resonance Imaging Clinical Trial

Official title: A Single Institution Registry Trial Evaluating the Safety of MRI for Patients With Non-MRI Conditional Pacemakers and ICD

Status Completed

Clinical Trial Summary

The purpose of the registry is to accumulate pre-and post-scan device interrogation data for the purpose of determining the risk of MRI for patients with implantable devices.

Clinical Trial Description

Registry Purpose

This registry is a prospective single institution study of MRI examinations in patients with pacemakers or ICD's who will undergo an MRI that is ordered for routine clinical care. The purpose of the registry is to accumulate pre-and post-scan device interrogation data for the purpose of determining the risk of MRI for patients with implantable devices.

Registry data will add to existing data on the safety of MRI scans for patients with pacemakers and ICDs. This safety data may impact physicians' diagnostic choices for this patient population. Patients with conditions for whom MRI is the best diagnostic modality but who have not been able to undergo MRI scanning may be able to do so through registry participation. The diagnostic information obtained from the scan may assist physicians' treatment decisions and may ultimately affect patient outcomes.

In addition, to our knowledge, previous registries of MRI's in non-conditional cardiac devices have been limited to academic centers. This registry would be among the first to demonstrate the feasibility and safety of this approach in a community hospital setting.

Study Methods

The registry research involves acquiring and analyzing the data of device function and adverse events related to the MRI scan.

The need for MRI will be determined on a case-by-case basis based on the patient's medical history and treatment plan/goals, independent of the registry and research purposes. Only patients with implanted devices with orders for clinically indicated MRI scans will be considered for registry inclusion. Clinical review will be performed and the patient considered after determination that no other imaging modality would be appropriate.

The appropriateness of the MRI study must be discussed, in person or via phone call, between a cardiac radiologist, as determined by Paul Leslie, M.D., and the requesting physician. The discussion should include consideration of alternative imaging modalities and diagnostic quality of MRI imaging of requested body region given implanted device(s). The requesting physician is then responsible for discussing with the patient and/or their medical proxy the reasoning for the determination, based on the final decision made by a radiologist.

All patients will be screened prior to enrollment. Any patient with any commercially available pacemaker or ICD system implanted after 2001 who meet all of the inclusion criteria and none of the exclusion criteria, and who require a medically-indicated MRI as described above will be eligible to enroll in the study. The presence/absence of capped/abandoned/epicardial leads/subcutaneous coil will be confirmed and documented by review of the most recent chest x-ray obtained. The x-ray must post-date the most recent device/lead intervention, as determined by a review of the patient's medical record.

If an MRI procedure is deemed absolutely necessary, the MRI will be performed at the Lancaster General Hospital Lime Street MRI facility. MRI scan sequences, field intensity and field(s) of exposure will be selected to minimize risk to the patient while gaining needed diagnostic information for diagnosis or therapy management.

The MRI will be performed with a 1.5 T scanner utilizing institutional protocols and the following settings:

• Normal operating mode

• SAR ≤ 2.0 W/kg per patient.

Prior to the procedure, a pacemaker technologist or manufacturer clinical representative will interrogate the pacemaker or ICD and record the following parameters:

• Patient's underlying rhythm

• Atrial and right/left ventricular pacing thresholds

• P-wave and R-wave amplitude

• Lead impedance (atrial, ventricular, high voltage)

• Battery voltage

• Arrhythmia history

• Tachyarrhythmia therapy

The following pacemaker/ICD parameters will be deactivated for the duration of the MRI:

• Magnet response (ICD)

• Rate response

• PVC response

• Noise reversion response

• Ventricular sense response

• Mode switching

• Tachycardia detection/therapies (ICD)

• EGM triggers

Patients who are not pacemaker dependent will have their pacemaker/ICD programmed to AAI/VVI/DDI at 40 beats per minute for the duration of the MRI. Patients who are pacemaker dependent (pacing at programmed lower rate during the pre-scan interrogation) will have their pacemaker/ICD programmed to AOO/VOO/DOO at the programmed lower rate for the duration of the MRI. Emergency equipment, including a MRI compatible defibrillator and transcutaneous pacemaker, will be available throughout the procedure in the event of an adverse clinical event. In addition to radiology staff, a pacemaker technologist or manufacturer clinical representative and an EP tech/RN with current ACLS will be present for the duration of the procedure. An EP physician/advanced practice provider (APP) must be immediately available (i.e., in the hospital) to provide medical intervention, such as placement of a temporary external pacemaker if required. In the event that a code is called by the MRI staff, hospital protocol indicates that ER staff will respond to the code.

Radiology staff and the electrophysiology (EP) technologist or nurse with current ACLS certification will monitor the following patient parameters at least every 5 minutes throughout the MRI scan:

• Heart rate

• Heart rhythm

• Non-invasive blood pressure

• Oxygen saturation

• Symptoms

If any of the following adverse symptoms/events occur during the scan, the test will be immediately terminated:

• Burning/pulling sensation in device pocket/chest during MRI

• Potentially lethal/previously non-diagnosed arrhythmias during MRI

• Spontaneous and unanticipated pacing rate change

• SOB

• Chest pain

• Feeling of heat/pulling in the chest or device pocket

The patient will be removed from the scanner to the holding area and the device interrogated and reprogrammed to original parameters or as indicated by interrogation. If needed, emergency treatment will be provided as per ACLS protocols or at the discretion of the monitoring physician. The following parameters will be compared to the pre-MRI results:

• Patient's underlying rhythm

• Atrial and right/left ventricular pacing thresholds

• P-wave and R-wave amplitude

• Lead impedance (atrial, ventricular, high voltage)

• Battery voltage

All device-related adverse events/symptoms will be documented on the data collection form and reported to the IRB. The patient will remain in the MRI suite holding area until medically stable. The need for further treatment will be at the discretion of the monitoring physician.

The EP physician/APP will review and compare the pre/post MRI device data prior to the patient's discharge from the MRI suite. Following testing, the pacemaker or ICD will be reprogrammed to the pre-procedure parameters. The need for device reprogramming related to the MRI scan will be based on the clinical judgment of the attending electrophysiologist.

Follow-up

Patients who do not experience any device related adverse events during the MRI will return for one follow-up visit 1-6 weeks after the MRI. The follow-up visit will include pacemaker/ICD interrogation and testing to confirm appropriate function. At a minimum, device interrogation/testing will include:

• Atrial and right/left ventricular pacing thresholds

• P-wave and R-wave amplitude

• Lead impedance (atrial, ventricular, high voltage)

• Battery voltage

Patients who experience one or more device-related adverse events during the MRI will return 1-7 days post-MRI for follow-up pacemaker/ICD testing to confirm appropriate function. At a minimum, device interrogation/testing will include:

• Atrial and right/left ventricular pacing thresholds

• P-wave and R-wave amplitude

• Lead impedance (atrial, ventricular, high voltage)

• Battery voltage

The need for further follow-up will be determined by the physician based on testing results and clinical need.

The results of the follow-up device interrogation, including whether MRI-related adverse events have resolved, will be documented and kept in the device chart and recorded in the Registry database.

If the insurance provider does not cover the MRI and device checks, those costs may be the full responsibility of the patient. The patient will be informed of the status of the pre-authorization before scheduling the MRI. ;

Related Conditions & MeSH terms

• Implantable Cardioverter Defibrillator
• Magnetic Resonance Imaging
• MRI Scans
• Pacemaker

• NCT number: NCT02318550
• Study type: Observational [Patient Registry]
• Source: Lancaster General Hospital
• Status: Completed
• Start date: December 2014
• Completion date: June 30, 2018